MILWAUKEE, Dec. 03, 2015 (GLOBE NEWSWIRE) -- We are investigating the Board of Directors of ARPI for possible breaches of fiduciary duty and other violations of state law in connection with the sale of ARPI to AMH.
Click here to learn how to join the action: http://www.ademilaw.com/case/arpi or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
ARPI long-term financial outlook is improving and yet ARPI shareholders will receive only 1.135 common shares or limited partnership units of AMH. AMH is well aware of ARPI improving financial metrics and is purchasing ARPI at a substantial discount. The merger agreement unreasonably limits prospective bids for ARPI by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should ARPI receive and accept a superior bid. ARPI insiders, their affiliates and other majority shareholders own significant voting stock, and will receive millions of dollars as part of change of control arrangements, and therefore can unduly influence a sale of ARPI not in the best interests of non-insiders. Our investigation centers on the conduct of ARPI Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for ARPI given its current financial condition and prospects.
If you own common shares or limited partnership units in ARPI and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://www.ademilaw.com/case/arpi.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Ademi & O’Reilly, LLP Guri Ademi 3620 East Layton Ave. Cudahy, WI 53110 Toll Free: (866) 264-3995 Fax: (414) 482-8001 www.ademilaw.com


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



